Form 4 for TARS Tarsus Pharmaceuticals, Inc.

Accepted 2026-09-17 16:47:49 ET · period of report 2026-09-15 · accession 0001051578-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2026-09-17 16:47	2026-09-15	TARS	PYOTT DAVID E I	Dir	M - OptEx	—	+201	9,575	+2%	—
D	2026-09-17 16:47	2026-09-15	TARS	PYOTT DAVID E I	Dir	M - OptEx	$0.00	-201	605	-25%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-15	M	A	201	—	9,575	I By the David E.I. Pyott Trust	—	—	(F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. (F2) Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares.
2	Derivative	Restricted Stock Units	2026-09-15	M	D	201	$0.00	605	D	— · — to —	201 Common Stock	(F3) Each RSU represents a contingent right to receive one share of the Company's common stock. (F4) RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. (F4) RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.